MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2016 International Congress

    Three cases of neuronal intranuclear inclusion disease (NIID)

    Y. Miyamoto, Y. Morita, K. Furuta, Y. Osaki, H. Arahata, A. Watanabe, N. Fujii, T. Iwaki, H. Furuya (Kochi, Japan)

    Objective: Here, we present three NIID cases. One of them, autopsy was performed. Background: Neuronal intranuclear inclusion disease (NIID)(OMIM 603472) is a neurodegenerative disorder characterized…
  • 2016 International Congress

    STUB1/CHIP mutations cause Gordon Holmes syndrome as part of widespread multisystemic neurodegeneration: Evidence from novel mutations

    S.N. Hayer, K. Smets, B. Bender, T. Deconinck, S. Züchner, L. Schöls, R. Schüle, P. De Jonghe, J. Baets, M. Synofzik (Tübingen, Germany)

    Objective: (1) To provide phenotypic and imaging evidence for a widespread neurodegenerative process caused by mutations in CHIP, thus demonstrating a close clinical correspondence to…
  • 2016 International Congress

    Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital

    S.C. Cerquera Cleves, S.J. Romero Vanegas, F. Cruz Sanabria, C. Ruiz de Sánchez, F.F. Pretelt Burgos (Bogotá, Colombia)

    Objective: To determine the discriminant ability of the Montreal Cognitive Assessment (MOCA) for detection of dementia or any cognitive impairment in patients with Parkinson's disease…
  • 2016 International Congress

    Predictors of dementia in Parkinson’s disease: A population-based cohort study

    A. Keener, K. Paul, A. Folle, J. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: To evaluate and describe characteristics of Parkinson's disease (PD) patients who develop dementia during follow-up in a longitudinal study. Background: Important non-motor features of…
  • 2016 International Congress

    Parkinsonism and movement disorders in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

    I. Amorín, A. Lescano, A. Panuncio, V. Raggio, R. Buzó (Montevideo, Uruguay)

    Objective: To study and report the frequency of movement disorders in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). Background: CADASIL is the main…
  • 2016 International Congress

    [18F]AV-1451 PET imaging of tau in progressive supranuclear palsy and Alzheimer’s disease

    J.B. Rowe, P. Vázquez Rodríguez, Y.T. Hong, R.J. Borchert, S. Sami, W.R. Bevan-Jones, S.P. Jones, R. Arnold, A. Surendranathan, E. Mak, S. Li, T. Fryer, J. O'Brien, L. Passamonti (Cambridge, United Kingdom)

    Objective: To evaluate: (1) brain tau pathology in vivo in patients with Progressive Supranuclear Palsy (PSP) and Alzheimer's disease (AD); (2) whether brain tau pathology…
  • 2016 International Congress

    Cognitive deficits in Parkinson’s disease: A preliminary study of neuropsychological profiles

    R.J. Giannaula, P.G. Sanz, J.C. Maiques, M.B. Seijas, M.J. González Aguilar, L. Grasso (Buenos Aires, Argentina)

    Objective: The purpose of this project was to examine cognitive deficits in a patient sample fulfilling the diagnostic criteria for idiopathic non-demented Parkinson's disease (PD)…
  • 2016 International Congress

    The role of neuroinflammation in the development of Parkinson’s disease dementia

    A. Kouli, R. Vuono, R.A. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)

    Objective: To evaluate, at post-mortem, the pattern and characteristics of neuroinflammatory change in Parkinson's disease (PD) brain and to assess its relationship with aberrant alpha-synuclein,…
  • 2016 International Congress

    Clinical profile of Parkinson’s disease at the neurology department of Point G Teaching Hospital

    T. Coulibaly, A.S. Sissoko, T. Coulibaly, L. Guida, K. Mamadou, G.C. Oumar (Bamako, Mali)

    Objective: To determine the frequency and clinical features of PD at the neurology department of Point G Teaching Hospital. Background: PD results from loss of…
  • 2016 International Congress

    Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment

    K. Kawabata, H. Watanabe, E. Bagarinao, N. Yoneyama, K. Hara, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: This study was designed to clarify the changes of detailed functional connectivity in association with phonemic fluency deficits in Parkinson's disease (PD) patients using…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley